Page 250 - IJB-8-3
P. 250

3D Printing and Vascularized Organ Construction
           A                        B                         C                        D












           E                        F                        G                         H











           I                        J                        K                         L











           M                        N                        O                         P











           Figure 6. 3D bioprinting of chondrocytes, cardiomyocytes, hepatocytes, and adipose-derived stem cells (ASCs) into living tissues/organs
           using a pioneered 3D bioprinter made at Prof. Wang’s laboratory in Tsinghua University: (A) The pioneered 3D bioprinter, (B) schematic
           description of a cell-laden gelatin-based hydrogel being printed into a grid lattice using the 3D bioprinter, (C) schematic description of
           the cell-laden gelatin-based hydrogel being printed into large scale-up 3D construct using the 3D bioprinter, (D) 3D printing process
           of a chondrocyte-laden  gelatin-based  construct,  (E) a grid 3D construct  made  from a cardiomyocyte-laden  gelatin-based  hydrogel,
           (F)  hepatocytes encapsulated in a gelatin-based hydrogel after 3D printing, (G) hepatocytes in a gelatin-based hydrogel after 3D printing,
           (H) a gelatin-based hydrogel after 3D printing, (I-P) hepatocytes in some gelatin-based hydrogels after certain periods of in vitro cultures.
           Reprinted from, Cryobiology, Vol 61 Issue 3, Wang X, Xu H, Incorporation of DMSO and dextran-40 into a gelatin/alginate hydrogel for
           controlled assembled cell cryopreservation, 345-351., Copyright (2010), with permission from Elsevier.

           bioartificial  organs  can  avoid  all  the  risks  of  vascular   In 2013, Professor Wang developed a combined four-
           rupture, stress shrinkage, immune rejection, and otherwise   nozzle 3D bioprinter for complex organ manufacturing
           reactions during the implantation stages [47,105,106] .  These   (Figure 9) . This system can be used for a wide range
                                                                        [66]
           are  all  long-awaited  breakthroughs  in  bioartificial  organ   of  bioartificial  organ  manufacturing [107-109] . At the same
           manufacturing  areas.  This  is  also  a  long-term  dream  for   time,  the concept of vascularization  and neutralization
           other pertinent hot research fields, such as tissue engineering,   of the large scale-up 3D-printed tissues has been adapted
           biomaterials, drug screening, organ transplantation, and   rapidly all over the world.
           pathological analysis, with respect to the in vitro automatic   Especially, with this integration of RP technology
           manufacturing processes and in vivo failed/defective organ   with  cell-laden  hydrogels,  all  the  bottleneck  problems,
           repair/replacement/restoration applications.        such as large scale-up tissue/organ manufacturing,

           242                         International Journal of Bioprinting (2022)–Volume 8, Issue 3
   245   246   247   248   249   250   251   252   253   254   255